ADV	adefovir
AFP	Alpha-fetoprotein
BCLC	Barcelona Clinic Liver Cancer classification
CHB	chronic hepatitis B
CHC	chronic hepatitis C
CI	confidence interval
CTLA-4	cytotoxic T-Lymphocyte antigen 4
DAA	direct acting antiviral agents
DFS	disease free survival
EMT	epithelial mesenchymal transition
ER	endoplasmic reticulum
ERK	extracellular signal-regulated kinase
ETV	entecavir
FXR	Farnesoid X receptor
HBsAg	hepatitis B surface antigen
HBV	hepatitis B virus
HBV-HCC	HBV related HCC
HCC	hepatocellular carcinoma
HCV	hepatitis C virus
HCV-HCC	HCV related HCC
HR	hazard ratio
IFN	interferon
LAM	lamivudine
MAIT	mucosal associated invariant T
NK	natural killer cell
Nuc	nucleos(t)ide analogues
OS	overall survival
PD-1	programmed cell death protein 1
Peg-IFN	pegylated interferon
RCT	randomized control trial
RFA	radiofrequency ablation
RFS	recurrence-free survival
ROS	reactive oxygen species
SVR	sustained virologic response
TAF	tenofovir alafenamide
TDF	tenofovir disoproxil fumarate
TERT	telomerase reverse transcriptase
TDF-β	transforming growth factor
Treg	regulatory T cell.